Podophyllotoxin derivatives

Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C548S526000, C549S298000

Reexamination Certificate

active

07342114

ABSTRACT:
4-O esters of podophyllotoxin and 4′-demethylepipodophyllotoxin are provided. The compounds are 4-O esters of an alkanoic acid or substituted alkanoic acid and podophyllotoxin and 4′-demethylepipodophyllotoxin. The compounds are useful for treating cancer.

REFERENCES:
patent: 3524844 (1970-08-01), Keller-Juslen
patent: 4965348 (1990-10-01), Saulnier et al.
patent: 6096336 (2000-08-01), Cao et al.
patent: 2837824 (2002-03-01), None
Nagao, Y et al ‘different mechanisms of action of long chain fatty acid esters of posophyllotoxin and esters of epipodophyllotoxin against P388 lymphocytic leukemia in mice’ CA 117:124013.
Nagao, Y et al ‘Preparation and testing of podophyllotoxin derivatives as neoplasm inhibitiors’ CA 112:7272.
Greenwald, RB et al ‘Drug delivery of anticncer agents: water soluble 4-polyethylene glycol derivatives ofhte lignan, podophyllotoxin’ CA 132:15517.
Lie, Ken Jie et al ‘Synthesis and spectral characteristics of some unusual fatty esters of podophyllotoxin’ CA 132:3273.
Weller et al, 21-day oral Etoposide for metastatic breast cancer: a phase II study and review of the literature, PMID: 10857889 (2000).
Wang, YG et al, Syntheses and structure-activity relationship ofpodophyllotoxin derivatives as potential anticancer drugs, CA 127:149030 (1997).
Pan, J et al, Syntesis of epipodophyllotoxin carboxylates and antitumor activity in vitro, CA 129:175488 (1998).
Fischer, PM et al, Preparation of peptide derivatives for improved delivery of drug therapeutic agents, CA 132:93654 (2000)0.
Mantle, Therapeutic applications of medicinal plants in the treatment of breast cancer: a review of their pharmacology, efficacy and tolerability, PMID: 11059361 (2000).
Pradhan, SN Effect of Various Drugs on the Tumor-necrotizing Activity of Several Chemical Agents in Mice, Cancer Research (1956) 1062-8.
Pan et al. STN Accension No. 1998:291310; Document No. 129:175488; Abstract of Yaoxue Xuebao 1997, 32(12), 898-901.
Brodin et al.,Acta Pharm Suec. 19: 267-284 (1982).
Forssen, et al.,Cancer Res, 52: 3255-3261 (1992).
Fung et al.,Biomater. Artif. Cells. Artif. Organs16: 439 et seq. (1988).
Gensler, et al.,J. Med. Chem. 20:5 635-644 (1977).
Hansen, et al.,Acta Chemi. Scand. 47: 1190-1200 (1993).
Khokhar, et al.,J. Med. Chem, 34: 325-329 (1991).
Lasic,Nature335: 279-280 (1992).
Lee et al.,Bio&Med. Chem. Ltrs. 7:22: 2897-2902 (1997).
Levy et al.,J. Pharm. Sci. 72:10: 1158-1160 (1983).
Perez-Soler, et al.,Cancer Res., 50: 4260-4266 (1990).
Santangelo et al.,Syn. Comm., 26:15: 2863-2873 (1996).
Supersaxo et al.,Pharm Res. 8: 1280-1291 (1991).
Thurston et al.,J. Med. Chem. 32: 604-608 (1989).
Yokoyama et al.,Cancer Res. 51: 3229-3236 (1991).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Podophyllotoxin derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Podophyllotoxin derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Podophyllotoxin derivatives will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3962546

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.